Form 8-K - Current report:
SEC Accession No. 0001299933-09-003670
Filing Date
2009-09-09
Accepted
2009-09-09 11:58:48
Documents
3
Period of Report
2009-09-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_34261.htm 8-K 10166
2 EX-99.1 exhibit1.htm EX-99.1 14144
3 GRAPHIC e27351-92521032086334087d_1.jpg GRAPHIC 26836
  Complete submission text file 0001299933-09-003670.txt   62932
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 091059757
SIC: 2834 Pharmaceutical Preparations